Nail involvement in adult patients with plaque-type psoriasis: prevalence and clinical features

被引:23
|
作者
Rosso Schons, Karen Regina [1 ]
Costa Beber, Andre Avelino [2 ]
Beck, Maristela de Oliveira [2 ]
Monticielo, Odirlei Andre [3 ]
机构
[1] Univ Passo Fundo, Passo Fundo, RS, Brazil
[2] Univ Fed Santa Maria, BR-97119900 Santa Maria, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
关键词
Dermatology; Nails; Psoriasis; QUALITY-OF-LIFE; SEVERITY; MODERATE; DISEASE; VALIDATION; MANAGEMENT; ARTHRITIS; THERAPY; BURDEN; SCALE;
D O I
10.1590/abd1806-4841.20153736
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND: Psoriasis is a disease of worldwide distribution with a prevalence of 1 to 3%. Nail psoriasis is estimated in 50% of patients with psoriasis, and in the presence of joint involvement, it can reach 80%. OBJECTIVE: To study the nail changes - and their clinical implications - presented by patients with psoriasis vulgaris under surveillance in a university hospital from the south of Brazil. METHODS: This cross-sectional study evaluated 65 adult patients from January 2012 to March 2013. Cutaneous severity was assessed according to the Psoriasis Area and Severity Index (PASI). The Nail Psoriasis Severity Index (NAPSI) was used to evaluate patient's nails. The diagnosis of psoriatic arthritis was established according to the Classification Criteria for Psoriatic Arthritis (CASPAR). RESULTS: The prevalence of NP was 46.1%. These patients had a median [interquartilic range (IQR)] NAPSI of 1 (015). A total of 63.3% of patients reported aesthetic discomfort or functional impairment related to their nails. Onycholysis was the most common feature (80%). When compared with patients without nail involvement, patients with NP had lower mean age at psoriasis onset [21 (18-41) vs. 43 (30-56) years, p=0,001]; longer disease duration [15.5 (10-24) vs. 6 (2-12) years, p=0.001]; higher PASI [9.2 (5-17) vs. 3.7 (2-10), p=0.044], higher frequency of psoriatic arthritis (43.3 vs. 3.7, p=0.002) and more often reported family history of psoriasis (40% vs. 7.4%, p=0.011). CONCLUSION: Onycholysis was the most frequent finding and most patients feel uncomfortable with the psoriatic nail changes that they experience.
引用
收藏
页码:314 / 319
页数:6
相关论文
共 50 条
  • [1] Arthritis and Nail Involvement In Patients With Plaque-Type Psoriasis
    Monticielo, Odirlei Andre
    Rosso Schons, Karen Regina
    Knob, Cristiane Faccin
    Neumaier, Walter
    Beck, Maristela de Oliveira
    Costa Beber, Andre Avelino
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S127 - S127
  • [2] Ultrasonographic findings in patients with chronic plaque-type psoriasis without musculoskeletal clinical involvement
    Dauden, E.
    Moller, I.
    De-Miguel, E.
    Batlle-Gualda, E.
    Acebes, C.
    Brito, E.
    Mayordomo, L.
    Moragues, C.
    Uson, J.
    De-Agustin, J. J.
    Martinez, A.
    Rejon, E.
    Rodriguez, A.
    Naredo, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 48 - 48
  • [3] Plaque-type psoriasis inhibitors
    Shobeiri, Saeideh Sadat
    Khorrami, Motahareh
    Sankian, Mojtaba
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [4] Clinical and cytokine profile evaluation in Northeast Brazilian psoriasis plaque-type patients
    Pablo Ramon Gualberto Cardoso
    Emerson Vasconcelos de Andrade Lima
    Mariana Modesto de Andrade Lima
    Moacyr Jesus Barreto de Melo Rêgo
    Claudia Diniz Lopes Marques
    Ivan da Rocha Pitta
    Angela Luzia Branco Pinto Duarte
    Maira Galdino da Rocha Pitta
    European Cytokine Network, 2016, 27 : 1 - 5
  • [5] Clinical and cytokine profile evaluation in Northeast Brazilian psoriasis plaque-type patients
    Gualberto Cardoso, Pablo Ramon
    de Andrade Lima, Emerson Vasconcelos
    de Andrade Lima, Mariana Modesto
    Barreto de Melo Rego, Moacyr Jesus
    Lopes Marques, Claudia Diniz
    Pitta, Ivan da Rocha
    Branco Pinto Duarte, Angela Luzia
    da Rocha Pitta, Maira Galdino
    EUROPEAN CYTOKINE NETWORK, 2016, 27 (01) : 1 - 5
  • [6] A dermoscopy subpattern of plaque-type psoriasis
    Vazquez-Lopez, Francisco
    Zaballos, Pedro
    Fueyo-Casado, Alejandro
    Sanchez-Martin, Jesus
    ARCHIVES OF DERMATOLOGY, 2007, 143 (12) : 1612 - 1612
  • [7] Atorvastatin for the Treatment of Plaque-Type Psoriasis
    Faghihi, Toktam
    Radfar, Mania
    Mehrabian, Zohre
    Ehsani, Amir Hoshang
    Hemami, Mohsen Rezaei
    PHARMACOTHERAPY, 2011, 31 (11): : 1045 - 1050
  • [8] Primary annular plaque-type psoriasis
    Guill, CL
    Hoang, MP
    Carder, KR
    PEDIATRIC DERMATOLOGY, 2005, 22 (01) : 15 - 18
  • [9] Management of plaque-type psoriasis in the adult: the Italian national clinical guidelines (ed. 2013)
    Mantarro, S.
    Cusano, F.
    D'Angelo, F.
    La Corte, E.
    Castriota, M.
    Pezza, M.
    Puca, R. V.
    De Masi, S.
    De Pita, O.
    Blandizzi, C.
    Mele, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 19 - 19
  • [10] Optimal concentration range of ustekinumab in patients with plaque-type psoriasis
    Martin-Gonzalez, Sergio
    Urigoitia-Ugalde, Peru
    Careaga, Jesus
    Nagore, Daniel
    Navarro, Rosaura
    Izu-Belloso, Rosa
    Blanch, Laura
    Gonzalez del Tanago, Jaime
    Martinez, Antonio
    Ruiz del Agua, Ainhoa
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (06) : 1782 - 1784